Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Gonzalez

Showing results (361-370 of 439) with videos related to

Pageof 44
Sort By:
Jornal De Pediatria|May 21, 2013
Impact of parental smoking on childhood asthmaFrancisco-Javier Gonzalez-Barcala, Sonia Pertega, Manuel Sampedro, et al.
Neuro-Oncology|August 24, 2010
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastomaMark R Gilbert, Javier Gonzalez, Kathy Hunter, et al.
Open Respiratory Archives|January 6, 2025
Respiratory Pathology and Cardiovascular Diseases: A Scoping ReviewFrancisco Campos-Rodríguez, Eusebi Chiner, David de la Rosa-Carrillo, et al.
Journal of the American Chemical Society|September 13, 2002
Iterative high-throughput polymorphism studies on acetaminophen and an experimentally derived structure for form IIIMatthew L Peterson, Sherry L Morissette, Chris McNulty, et al.
Cancer Research Communications|March 27, 2023
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent <i>IDH1-</i> and <i>IDH2</i>-mutant GliomaKristina Fanucci, Mary Jo Pilat, Derek Shyr, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 25, 2025
Effectiveness and safety of cefiderocol treatment in patients with Gram-negative bacterial infections in Spain in the early access programme: results of the PERSEUS studyJulian Torre-Cisneros, Benito Almirante, Carmen De La Fuente Martos, et al.
Journal of Medicinal Chemistry|July 31, 2007
Allosteric inhibitors of hepatitis C polymerase: discovery of potent and orally bioavailable carbon-linked dihydropyronesHui Li, Angelica Linton, John Tatlock, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2006
Identification and structure-based optimization of novel dihydropyrones as potent HCV RNA polymerase inhibitorsHui Li, John Tatlock, Angelica Linton, et al.
International Journal of Social Robotics|February 23, 2022
Integrating Social Assistive Robots, IoT, Virtual Communities and Smart Objects to Assist at-Home Independently Living Elders: the MoveCare ProjectMatteo Luperto, Javier Monroy, Jennifer Renoux, et al.
Clinical Lung Cancer|July 15, 2020
Response to the Selective RET Inhibitor Selpercatinib (LOXO-292) in a Patient With RET Fusion-positive Atypical Lung CarcinoidElizabeth M Kander, Manisha H Shah, Ye Zhou, et al.
Pageof 44

Showing results (361-370 of 439) with videos related to

Sort By:
Pageof 44
Jornal De Pediatria|May 21, 2013
Impact of parental smoking on childhood asthmaFrancisco-Javier Gonzalez-Barcala, Sonia Pertega, Manuel Sampedro, et al.
Neuro-Oncology|August 24, 2010
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastomaMark R Gilbert, Javier Gonzalez, Kathy Hunter, et al.
Open Respiratory Archives|January 6, 2025
Respiratory Pathology and Cardiovascular Diseases: A Scoping ReviewFrancisco Campos-Rodríguez, Eusebi Chiner, David de la Rosa-Carrillo, et al.
Journal of the American Chemical Society|September 13, 2002
Iterative high-throughput polymorphism studies on acetaminophen and an experimentally derived structure for form IIIMatthew L Peterson, Sherry L Morissette, Chris McNulty, et al.
Cancer Research Communications|March 27, 2023
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent <i>IDH1-</i> and <i>IDH2</i>-mutant GliomaKristina Fanucci, Mary Jo Pilat, Derek Shyr, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 25, 2025
Effectiveness and safety of cefiderocol treatment in patients with Gram-negative bacterial infections in Spain in the early access programme: results of the PERSEUS studyJulian Torre-Cisneros, Benito Almirante, Carmen De La Fuente Martos, et al.
Journal of Medicinal Chemistry|July 31, 2007
Allosteric inhibitors of hepatitis C polymerase: discovery of potent and orally bioavailable carbon-linked dihydropyronesHui Li, Angelica Linton, John Tatlock, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2006
Identification and structure-based optimization of novel dihydropyrones as potent HCV RNA polymerase inhibitorsHui Li, John Tatlock, Angelica Linton, et al.
International Journal of Social Robotics|February 23, 2022
Integrating Social Assistive Robots, IoT, Virtual Communities and Smart Objects to Assist at-Home Independently Living Elders: the MoveCare ProjectMatteo Luperto, Javier Monroy, Jennifer Renoux, et al.
Clinical Lung Cancer|July 15, 2020
Response to the Selective RET Inhibitor Selpercatinib (LOXO-292) in a Patient With RET Fusion-positive Atypical Lung CarcinoidElizabeth M Kander, Manisha H Shah, Ye Zhou, et al.
Pageof 44